The 2026 Good Neighbor Pharmacy FDD holds the Item 7 estimated initial investment range at $43,797–$556,405, and the system contracts from 2,361 to 2,204 outlets (−6.6%) year-over-year. The 2026 filing adds an Item 19 financial performance representation that the 2025 filing did not include.
| 2025 FDD | 2026 FDD | Change | |
|---|---|---|---|
| Low end of range | $43,797 | $43,797 | unchanged |
| High end of range | $556,405 | $556,405 | unchanged |
| Full range | $43,797–$556,405 | $43,797–$556,405 |
The Item 7 estimated initial investment range matches across both filings at $43,797–$556,405.
2025 filing: Item 7 provides separate total estimated initial investment ranges for an existing pharmacy and a start-up pharmacy; the range shown here is the 'Existing Pharmacy' total. 2026 filing: Monthly fees, such as the $599 Premier Fee and various program fees, are listed in Item 6; the specific amounts for optional programs are provided in separate term sheets and vary by enrollment choices.
| 2025 FDD | 2026 FDD | Change | |
|---|---|---|---|
| Total outlets (Item 20) | 2,361 | 2,204 | −157 (−6.6%) |
| Franchised outlets | 2,204 | 2,204 | unchanged |
| Company-owned outlets | 0 | 0 | unchanged |
| Openings during the year | 174 | 174 | unchanged |
| Closures during the year | 264 | 264 | unchanged |
Good Neighbor Pharmacy reports 2,204 outlets in the 2026 FDD, against 2,361 in the 2025 filing — a change of −157 (−6.6%).
Outlet counts as each filing states them — 2025: Fiscal year ended September 30, 2025; 2026: As of September 30, 2025. Outlet summary figures in Item 20 reflect active GNP Premier Pharmacies as of fiscal year-end; company-owned units remain at zero.
The 2026 Good Neighbor Pharmacy filing adds an Item 19 financial performance representation; the 2025 filing did not include one. It discloses financial performance.
Neither filing states Good Neighbor Pharmacy's ongoing royalty as a single percentage rate, so there is no rate to compare year-over-year.
2025 filing: No royalty is listed in Item 6; the disclosed recurring fee is a monthly GNP Premier Fee. 2026 filing: No ongoing royalty percentage or minimum royalty is specified in Item 6.